Fmoc-3-Trifluoromethyl-L-Phenylalanine

Fmoc-3-Trifluoromethyl-L-Phenylalanine is an Fmoc-protected L-phenylalanine derivative bearing a 3-(trifluoromethyl) substituent on the aromatic side chain, creating a chiral amino acid building block with a stereogenic center at the alpha carbon. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino function and a carboxylic acid handle suitable for amide formation after coupling, while the electron-withdrawing CF3 group modulates aromatic reactivity and physicochemical properties. The aryl CF3 substituent can influence peptide conformational preferences, hydrophobicity, and metabolic stability trends in downstream analogs, and the protected amine supports controlled peptide assembly under standard Fmoc deprotection conditions. As a chiral amino acid intermediate, it is commonly handled as a defined stereochemical entity and can be converted into a sequence-defined peptidic or peptidomimetic framework.

1. Peptide Synthesis

Fmoc-3-Trifluoromethyl-L-Phenylalanine is applied in solid-phase peptide synthesis where the Fmoc group enables stepwise N-terminal protection and orthogonal deprotection to expose the amine for coupling. The alpha-amino acid architecture, including the Fmoc-protected nitrogen and the carboxylic acid, supports formation of amide bonds that incorporate the CF3-bearing phenylalanine side chain into peptide backbones. The CF3-substituted aromatic ring can be used to tune hydrophobic and electronic character of peptide segments, which can be relevant for generating sequence libraries and mechanistic probes. Peptide building block incorporation of this chiral residue supports downstream synthesis of fluorinated analogs for structure-defined studies in peptide science and medicinal chemistry workflows.

2. Peptidomimetics And SAR

Fmoc-3-Trifluoromethyl-L-Phenylalanine is used in peptidomimetic and structure-activity relationship studies where the CF3-modified phenyl side chain serves as a tunable pharmacophore element. The stereochemically defined L-configuration and protected amino acid format allow consistent placement of the aromatic CF3 group within analog scaffolds, supporting SAR-driven optimization of binding-site interactions. The electron-withdrawing CF3 substituent can modulate local polarity, aromatic electronics, and conformational behavior of the residue in constrained peptide-like structures. Incorporation into short peptides, constrained peptidomimetics, or hybrid oligomers enables systematic comparison of analogs synthesized from a common chiral building block.

3. Chemical Biology Probes

Fmoc-3-Trifluoromethyl-L-Phenylalanine is suitable for chemical biology research that requires residue-specific incorporation of fluorinated amino acid analogs into peptides used as biochemical probes. The Fmoc-protected amino acid format supports controlled assembly of labeled or functional peptide constructs, while the CF3-bearing aromatic side chain can act as a chemically stable handle that resists oxidative side reactions relative to more labile substituents. The resulting CF3-containing peptides can be employed in studies of molecular recognition, protein-ligand interactions, or pathway mapping where side-chain electronics and hydrophobicity influence binding. Downstream derivatization of the peptide scaffold, including further functional group installation on termini or side chains, can leverage the CF3 residue as an electronically tuned structural element.

4. Protected Amino Acid Chemistry

Fmoc-3-Trifluoromethyl-L-Phenylalanine is used as a protected amino acid intermediate for synthetic organic chemistry where Fmoc chemistry provides predictable protection and deprotection behavior during multi-step synthesis. The Fmoc carbamate masks the amine to prevent undesired side reactions, while the carboxylic acid functionality enables conversion into activated coupling partners or direct peptide coupling under standard amide-forming conditions. The chiral alpha-carbon stereochemistry is preserved through the protected intermediate stage, supporting stereocontrolled incorporation into larger molecules. The CF3-substituted aromatic moiety provides a fluorinated aromatic motif that can be retained through downstream transformations, enabling access to fluorinated amino acid derivatives and sequence-defined intermediates.

5. Pharmaceutical Intermediate Preparation

Fmoc-3-Trifluoromethyl-L-Phenylalanine is relevant to pharmaceutical intermediate preparation for generating fluorinated peptide fragments and peptidomimetic building blocks used in process chemistry. The presence of an Fmoc-protected amine and a carboxylic acid allows manufacturing-oriented route design that can include controlled coupling steps, purification by standard solid-phase or solution-phase workflows, and subsequent deprotection to yield reactive amino termini. The CF3-substituted phenylalanine residue can be used to introduce a fluorinated motif that often improves chemical robustness and can influence physicochemical properties of final peptide-like intermediates. Downstream formation of drug-discovery scaffolds, including analog series assembled from protected amino acid building blocks, connects amino acid derivatization with scalable fine chemical production.

6. Analytical Standards And LC-MS Workflows

Fmoc-3-Trifluoromethyl-L-Phenylalanine is employed in analytical research and method development where CF3-containing amino acid standards support identification and quantification of fluorinated peptide components. The defined stereochemistry and Fmoc-protected structure provide a reproducible reference material for monitoring peptide synthesis progress, verifying incorporation of the CF3-phenylalanine residue, and calibrating analytical signals. The CF3 group enhances detectability in many mass spectrometric workflows due to its characteristic fragmentation behavior and strong mass signature. Preparation of this protected amino acid as an analytical comparator supports downstream quality control of peptide building block preparation, intermediate verification, and fluorinated analog characterization in synthetic and manufacturing contexts.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis